Banc de Sang i Teixits (BST), Barcelona, Spain.
Chair of Transfusion Medicine and Cellular and Tissue Therapies, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Blood Transfus. 2021 Mar;19(2):158-167. doi: 10.2450/2021.0259-20. Epub 2021 Jan 15.
The COVID-19 pandemic is placing blood and tissue establishments under unprecedented stress, putting its capacity to provide the adequate care needed at risk. Here we reflect on how our integrated organisational model has faced the first impact of the pandemic and describe what challenges, opportunities and lessons have emerged.
The organisational model of the Catalan Blood and Tissue Bank (Banc de Sang i Teixits, BST) is described. The new scenario was managed by following international recommendations and considering the pandemic in a context of volatility, uncertainty, complexity, and ambiguity (VUCA), allowing rapid measures to be taken. These aimed to: ensure donor safety, promote proper responses to patients' needs, ensure the health and well-being of personnel, and prepare for future scenarios.
The BST has adapted its activities to the changes in demand. No shortage of any product or service occurred. Donor acceptance, safety and wellbeing were maintained except for tissue donation, which almost completely stopped. To support the health system, several activities have been promoted: large-scale convalescent plasma (CP) production, clinical trials with CP and mesenchymal stromal cells, massive COVID-19 diagnoses, and participation in co-operative research and publications. Haemovigilance is running smoothly and no adverse effects have been detected among donors or patients.
Several elements have proven to be critical when addressing the pandemic scenario: a) the early creation of a crisis committee in combination with technical recommendations and the recognition of a VUCA scenario; b) identification of the strategies described; c) the integrated donor-to-patient organisational model; d) active Research and Development (R&D); and e) the flexibility of the staff. It is essential to underline the importance of the need for centralised management, effective contingency strategies, and early collaboration with peers.
COVID-19 大流行使血液和组织机构面临前所未有的压力,使其提供所需的充分护理的能力面临风险。在这里,我们反思我们的综合组织模式如何应对大流行的第一波冲击,并描述出现的挑战、机遇和经验教训。
描述了加泰罗尼亚血液和组织银行(Banc de Sang i Teixits,BST)的组织模式。根据国际建议,在考虑大流行的波动性、不确定性、复杂性和模糊性(VUCA)的背景下,对新情况进行了管理,并采取了快速措施。这些措施旨在:确保供者安全,促进对患者需求的适当响应,确保人员的健康和福祉,并为未来的情况做好准备。
BST 已经调整了其活动以适应需求的变化。没有出现任何产品或服务短缺的情况。除了组织捐赠几乎完全停止外,供者的接受、安全和福利得到了维持。为了支持卫生系统,已经开展了几项活动:大规模生产恢复期血浆(CP)、CP 和间充质基质细胞的临床试验、大规模 COVID-19 诊断以及参与合作研究和出版物。血液警戒系统运行平稳,在供者或患者中没有发现不良反应。
在应对大流行情况时,有几个因素被证明是至关重要的:a)早期成立危机委员会,结合技术建议和认识到 VUCA 情况;b)确定描述的策略;c)综合的供者到患者组织模式;d)积极的研究和开发(R&D);和 e)员工的灵活性。必须强调集中管理、有效的应急策略以及与同行的早期合作的重要性。